You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

12 April 2018

India could shift from efavirenz to dolutegravir for HIV treatment – at no extra cost, new research suggests

Researchers recommend dolutegravir (DTG)‐based antiretrovirals should become the first option for HIV treatment in India, following a study into DTG’s cost-effectiveness.

09 April 2018

HIV criminalisation deters men from testing and can increase HIV transmission rates

Findings show that fear of prosecution can drive new infections, as it puts men off knowing their status.

05 April 2018

Violence a major driver for teens not taking their HIV treatment

Adolescent treatment non-adherence remains a major challenge in sub-Saharan Africa. Addressing structural barriers to care retention, such as violence, could be key.

28 March 2018

New research explores the reasons men stop taking PrEP

Research reveals that most gay and bisexual men who stop taking pre-exposure prophylaxis (PrEP) in the USA do so because it is too expensive or they see themselves as no longer having a need for it.  

22 March 2018

One-fifth of all cancers in people living with HIV could have been avoided by not smoking

Nearly one-fifth (19%) of all cancers among people living with HIV could have been avoided by not smoking according to a recent study among people living with HIV in North America.

07 March 2018

Cash transfers reduce risk of intimate partner violence for young girls in South Africa

Study finds that the risk of physical intimate partner violence (IPV) is reduced by giving regular cash payments to poor girls, but HIV infection rates are not affected.

16 February 2018

People in poorer countries in Latin America and the Caribbean adhere better to HIV treatment

New study provides insights into the factors that influence treatment adherence in Latin America and the Caribbean. Results show that individuals from lower resource settings often achieve higher levels of adherence, contrary to predictions. 

05 February 2018

New data helps prioritise groups for HIV treatment in low resourced settings

Lancet study reveals for the first time who can benefit most from immediate antiretroviral treatment – enabling prioritisation in low-resourced settings. But who is left behind?

01 February 2018

Disruptions in PrEP adherence provide insights into intimate partner violence

New study finds strong links between PrEP disruptions and intimate partner violence in Kenya and Uganda. Combined interventions could be key to improving adherence and linking victims to support services.

30 January 2018

Chemsex is an issue among gay men living with HIV in the UK, study reveals

With three in ten gay men living with HIV engaging in chemsex in the last year in the UK, understanding its association with the country’s HIV and STI epidemics is critical to put an end to new infections.